Navigation Links
Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial
Date:2/9/2011

ration of retrieval device to remove clot in acute ischemic stroke. Concentric Medical is the pioneer in developing devices for ischemic stroke intervention. Since 2002, Concentric Medical's devices have been used in thousands of stroke patients worldwide. This experience has been incorporated into the design of the Trevo System to make thrombus removal an easier, faster and more predictable procedure. The new Trevo System combined with the Merci® portfolio of Retrievers and DAC™ catheters further strengthens Concentric Medical's position as the global leader in acute ischemic stroke intervention.  

About Acute Ischemic StrokeStroke is a leading cause of death in the developed world and the leading cause of serious long-term disability. Ischemic stroke represents over 85% of strokes and occurs when a blockage or clot develops in one of the arteries supplying blood to the brain. CE mark for the Merci Retriever was first obtained in 2002. In 2004 the FDA cleared Concentric Medical's Merci Retriever® for use in patients who are ineligible for IV-tPA or who fail to respond to IV-tPA therapy. This pioneering device creates a departure from the historic method of caring for stroke patients and offers physicians and patients a long-awaited option for stroke intervention.Media Contact:+1 650-938-2100strokeinfo@concentric-medical.com
'/>"/>

SOURCE Concentric Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Concentric Medical to Sponsor Randomized Trial
2. Concentric Medical and the Merci Retrieval System(R) Highlighted at the 2010 International Stroke Conference
3. Concentric Medical Announces Product and Procedure Reimbursement as Well as Full Commercialization of the Merci Retriever® in Japan
4. Concentric Medical Announces Commercial Launch of Trevo™ in Europe
5. Concentric Medical Announces First Stroke Patients Treated in Canada with Trevo™ System
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Globus Medical Raises $110 Million in Series E Financing Round
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. Boston University Biomedical Engineers Find Chink in Bacterias Armor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
(Date:1/15/2014)... 2014  Novation, the leading health care supply chain expertise, ... reseller (VAR) national contracts that expand its portfolio to ... lower costs. These include manufacturer product and service agreements, ... and ongoing IT consulting support. New ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the development and sale of patented ... generics and active pharmaceutical ingredients (API) announced that ... Macrolide Facility (JCM) has passed the internal quality ...
... NEW YORK, Nov. 9, 2011 ... research report is available in its ... and Reimbursement in Europe - Reference ... to Innovative Drugs Pose Significant Challenge ...
Cached Medicine Technology:JCM Passes Internal Quality Assessment for Azithromycin API Production 2JCM Passes Internal Quality Assessment for Azithromycin API Production 3Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 2Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 3Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 4Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 5Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 6Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies 7
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- Prostate cancer patients ... receive less effective treatment and die sooner if they ... analyzed data from more than 41,200 American men who ... 2007. They followed them through 2009. Nearly 1,900 of ... two years before their prostate cancer was discovered. ...
(Date:7/11/2014)... Sacramento, CA (PRWEB) July 11, 2014 ... Luke Bryan Tickets at the Sleep Train Amphitheatre in ... few venues that can compare to what the Sleep Train ... countless musical events and special attractions over the course of ... October 16th, the Sleep Train Amphitheatre in Wheatland (Sacramento metro ...
(Date:7/11/2014)... 2014 Last month Watkins Insurance Group ... joins the agency as a specialist in insurance and ... a Bachelor’s Degree in Business Administration from Texas State ... will manage everything from performance and payment bonds, license ... specialized needs for those in the asphalt supplier industry. ...
(Date:7/11/2014)... The “Proteomics Market by Technology ... Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents ... and studies the major market drivers, restraints, and ... Rest of the World (RoW). , The proteomics ... few years, mainly due to the increasing need ...
(Date:7/11/2014)... many years scientists have been trying to unravel mechanisms ... those cells that generate all blood cells including our ... is difficult because they can only be found in ... recapitulated in a culture dish. Now a group of ... Claudia Waskow (Technische Universitt Dresden) was able to generate ...
Breaking Medicine News(10 mins):Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 2Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 4Health News:Opening-up the stem cell niche 2
... from Allergy UK disclosed that food allergies are the reasons ... research was conducted among the British residents who have encountered ... end of this interesting survey, it was found out that ... health problems. ,Lactose intolerance is one of the ...
... University of Adelaide in the Discipline of Pharmacology have ... of heroin addicts around// the world. They have ... dosage levels for heroin addicts. ,The study ... effective in distributing drugs throughout their body to the ...
... study by Dr. David Goltzman, a professor of medicine and ... Periodontal Research at McGill University in Montreal//, and colleagues, have ... medicine and psychiatry. , Elderly persons aged above ... increased fractures. , The study published in the Archives ...
... Scientists at the University of Pennsylvania School of Medicine ... that could be "linked to the patient's thoughts, providing ... external stimuli." ,"We're at a junction now ... says senior author Douglas H. Smith, MD, Professor of ...
... at Rice University and pediatric specialists at Baylor College of ... buckyball nanoparticles as passkeys that allows drugs to enter cancer ... 21 issue of the journal Organic and Biomolecular Chemistry. ... outside world. Cell walls, or membranes, form a protective cocoon ...
... by researchers from the February issue of the American ... are more likely// to eat their offspring when they ... ,"The most drastic decision a father can make ... (Ph.D. candidate at Simon Fraser University), Lawrence Dill (Simon ...
Cached Medicine News:Health News:Genetic-Key to Stop Heroin Addicts 2Health News:Prozac-popping Elders at Higher Risk of Fractures 2Health News:New Ideas on Developing Thought-Controlled Artificial Limbs 2Health News:Buckyballs Used as 'Passkey' into Cancer Cells 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... used in the ARED study, as well ... which suggested no AMD disease progression in ... period. Macula Complete also contains efficacious amounts ... support the mitochondria, as well as to ...
... MacularProtect delivers levels of ... vision and macular health in ... by The National Eye Institute. ... of lutein, an antioxidant found ...
... is a scientifically advanced nutritional formulation ... and full body health. MacularProtect Complete ... trial and other advanced research. It ... provides a broad foundation of antioxidants, ...
Medicine Products: